| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 42.209 | 72.212 | 91.127 | 79.138 | 83.721 | 116.921 | 176.049 |
| Total Income - EUR | - | - | - | 42.209 | 72.212 | 91.127 | 79.138 | 83.721 | 116.921 | 176.512 |
| Total Expenses - EUR | - | - | - | 46.309 | 66.873 | 79.128 | 76.709 | 81.346 | 112.228 | 160.148 |
| Gross Profit/Loss - EUR | - | - | - | -4.100 | 5.339 | 12.000 | 2.429 | 2.375 | 4.693 | 16.364 |
| Net Profit/Loss - EUR | - | - | - | -4.522 | 4.224 | 10.721 | 1.727 | 1.083 | 3.857 | 13.901 |
| Employees | - | - | - | 2 | 1 | 1 | 1 | 2 | 1 | 1 |
Check the financial reports for the company - Bio Chris Pharma S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 979 | 932 | 824 | 529 | 292 | 0 | 10.000 |
| Current Assets | - | - | - | 5.007 | 7.084 | 11.655 | 10.178 | 10.253 | 23.095 | 23.076 |
| Inventories | - | - | - | 4.378 | 6.175 | 7.677 | 7.972 | 8.393 | 18.486 | 18.766 |
| Receivables | - | - | - | 0 | 0 | 1.244 | 1.182 | 1.108 | 2.952 | 2.455 |
| Cash | - | - | - | 629 | 909 | 2.735 | 1.024 | 751 | 1.658 | 1.854 |
| Shareholders Funds | - | - | - | -4.479 | -169 | 10.555 | 6.622 | 1.328 | 5.138 | 19.010 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 10.478 | 8.243 | 2.110 | 4.085 | 9.216 | 17.957 | 14.325 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4729 - 4729" | |||||||||
| CAEN Financial Year |
4729
|
|||||||||
Comments - Bio Chris Pharma S.r.l.